Press Releases
-
MURAL HEALTH AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS
MURAL HEALTH, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and LEDGER RUN, an innovative technology company focused on optimizing clinical operations, today announced a strategic partnership. Through this partnership, Mural Health’s Mural Link™ platform and Ledger Run’s unique ClinRun™ platform work together to improve clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.
Jan 31, 2023
-
Clinion is exhibiting at ISCR Annual Conference being held on 24-25 FEB, 2023 in Delhi
Schedule a Time to Meet us at the Event Book Your Slot Now Clinion is thrilled to be a part of this prestigious conference and look forward to networking with some of the top minds in the field. We hope
Jan 31, 2023
-
Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Novel AAV Capsid Anc80 enables efficient gene transfer
Jan 30, 2023
-
Verisense Health, a Shimmer Research Spin-off, Launches as a Digital Health Software and Data Management Company
Verisense® Health, Inc. launched today as a digital health software and data management company. It was established with the goal of providing sponsors with cost-efficient access to a digital biobank of longitudinal raw patient data. The new company is a spin-off from Dublin-based wearable technology services and sensor manufacturer Shimmer Research.
Jan 29, 2023
-
Creative Proteomics Revised Its Molecular-Interaction Subsite for a Better User Experience
-
Creative Proteomics Lipidomics Upgrades Its Medium-Chain and Long-Chain Fatty Acids Analysis Service
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Gut Microbiota Metabolomics Solution
-
CD BioGlyco Developed Various Strategies for Sialic Acid Analysis
-
Creative BioMart Provides Game-changing Microbial Solutions for Drug Development
-
Profacgen Provides a Complete Set of PEGylation Products and Services for Research Use
-
MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research
-
CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research
-
CD Genomics Introduces Professional and Mature Long Amplicon Analysis Service
-
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
-
Elligo Adds AI-Driven Clinical Research Study Technology to Accelerate Trials
-
Kroger Health Establishes Clinical Trial Site Network to Increase Reach and Access to Research Studies
Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial
Jan 24, 2023
-
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Jan 23, 2023
-
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference
Jan 23, 2023
-
Taking Medical Coding to the next level with AI and Machine Learning
AI is transforming medical coding by improving coding accuracy. In this blog, we’ll explore what this transformation means for clinical trial organizations.
Jan 19, 2023
-
CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients
CureSearch for Children's Cancer is collaborating with Children's Oncology Group (COG), Labcorp Drug Development, Pfizer, UTHealth Houston School of Public Health, and Thermo Fisher Scientific on a new study to examine the economic and treatment benefits of molecular testing for childhood cancer patients.
Jan 17, 2023